XML 50 R32.htm IDEA: XBRL DOCUMENT
v3.24.0.1

SHAREHOLDERS' EQUITY (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Equity [Abstract] |
Schedule of employee and non-employee shares options activity |
|  | Number |  |  | Weighted average exercise price |  |  | Weighted average remaining contractual life (years) |  |  | Aggregate intrinsic value (in thousands) |
Options outstanding at the beginning of the year |  |  | 43,994 |  |  | $ | 41.27 |  |  |  | 4.39 |  |  | $ | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | (10,823 | ) |  |  | 52.78 |  |  |  | - |  |  |  | - |
Options outstanding at the end of the year |  |  | 33,171 |  |  | $ | 37.51 |  |  |  | 4.39 |  |  | $ | - |
Options exercisable at the end of the year |  |  | 33,171 |  |  | $ | 37.51 |  |  |  | 4.39 |  |  | $ | - |
Schedule of employee and non-employee RSUs activity |
|  | Number of shares underlying outstanding RSUs |  |  | Weighted- average grant date fair value |
Unvested RSUs at the beginning of the year |  |  | 2,755,057 |  |  |  | 1.16 |
Granted |  |  | 2,258,370 |  |  |  | 0.66 |
Vested |  |  | (1,109,200 | ) |  |  | 1.14 |
Forfeited |  |  | (131,813 | ) |  |  | 1.13 |
Unvested RSUs at the end of the year |  |  | 3,772,414 |  |  |  | 0.87 |
Schedule of options and RSUs outstanding |
Range of exercise price |  | Options and RSUs Outstanding as of December 31, 2023 |  |  | Weighted average remaining contractual life (years) (1) |  |  | Options Exercisable as of December 31, 2023 |  |  | Weighted average remaining contractual life (years) (1) |
RSUs only |  |  | 3,772,414 |  |  |  | - |  |  |  | - |  |  |  | - |
$5.37 |  |  | 12,425 |  |  |  | 5.24 |  |  |  | 12,425 |  |  |  | 5.24 |
$20.42- $33.75 |  |  | 12,943 |  |  |  | 4.35 |  |  |  | 12,943 |  |  |  | 4.35 |
$50-$52.5 |  |  | 6,230 |  |  |  | 3.46 |  |  |  | 6,230 |  |  |  | 3.46 |
$182.5-$524.25 |  |  | 1,573 |  |  |  | 1.65 |  |  |  | 1,573 |  |  |  | 1.65 |
|  |  | 3,805,585 |  |  |  | 4.39 |  |  |  | 33,171 |  |  |  | 4.39 |
Schedule of non-cash share-based compensation expense |
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |  |  | 2021 |
Cost of revenue |  | $ | 9 |  |  | $ | 16 |  |  | $ | 10 |
Research and development, net |  |  | 157 |  |  |  | 94 |  |  |  | 55 |
Sales and marketing |  |  | 381 |  |  |  | 250 |  |  |  | 171 |
General and administrative |  |  | 781 |  |  |  | 633 |  |  |  | 597 |
Total |  | $ | 1,328 |  |  | $ | 993 |  |  | $ | 833 |
Schedule of warrants outstanding and exercisable |
Issuance date |  | Warrants outstanding |  |  | Exercise price per warrant |  |  | Warrants outstanding and exercisable |  | Contractual term
|  | (number) |  |  |  |  |  | (number) |  |
December 31, 2015 (1) |  |  | 4,771 |  |  | $ | 7.500 |  |  |  | 4,771 |  | See footnote (1)
December 28, 2016 (2) |  |  | 1,908 |  |  | $ | 7.500 |  |  |  | 1,908 |  | See footnote (1)
February 25, 2019 (5) |  |  | 45,600 |  |  | $ | 7.187 |  |  |  | 45,600 |  | February 21, 2024
April 5, 2019 (6) |  |  | 408,457 |  |  | $ | 5.140 |  |  |  | 408,457 |  | October 7, 2024
April 5, 2019 (7) |  |  | 49,015 |  |  | $ | 6.503 |  |  |  | 49,015 |  | April 3, 2024
June 5, 2019, and June 6, 2019 (8) |  |  | 1,464,665 |  |  | $ | 7.500 |  |  |  | 1,464,665 |  | June 5, 2024
June 5, 2019 (9) |  |  | 87,880 |  |  | $ | 9.375 |  |  |  | 87,880 |  | June 5, 2024
June 12, 2019 (10) |  |  | 416,667 |  |  | $ | 6.000 |  |  |  | 416,667 |  | December 12, 2024
June 10, 2019 (11) |  |  | 50,000 |  |  | $ | 7.500 |  |  |  | 50,000 |  | June 10, 2024
February 10, 2020 (12) |  |  | 28,400 |  |  | $ | 1.250 |  |  |  | 28,400 |  | February 10, 2025
February 10, 2020 (13) |  |  | 105,840 |  |  | $ | 1.563 |  |  |  | 105,840 |  | February 10, 2025
July 6, 2020 (14) |  |  | 448,698 |  |  | $ | 1.760 |  |  |  | 448,698 |  | January 2, 2026
July 6, 2020 (15) |  |  | 296,297 |  |  | $ | 2.278 |  |  |  | 296,297 |  | January 2, 2026
December 8, 2020 (16) |  |  | 586,760 |  |  | $ | 1.340 |  |  |  | 586,760 |  | June 8, 2026
December 8, 2020 (17) |  |  | 108,806 |  |  | $ | 1.792 |  |  |  | 108,806 |  | June 8, 2026
February 26, 2021 (18) |  |  | 5,460,751 |  |  | $ | 3.600 |  |  |  | 5,460,751 |  | August 26, 2026
February 26, 2021 (19) |  |  | 655,290 |  |  | $ | 4.578 |  |  |  | 655,290 |  | August 26, 2026
September 29, 2021 (20) |  |  | 8,006,759 |  |  | $ | 2.000 |  |  |  | 8,006,759 |  | March 29, 2027
September 29, 2021 (21) |  |  | 960,811 |  |  | $ | 2.544 |  |  |  | 960,811 |  | September 27, 2026
|  |  | 19,187,375 |  |  |  |  |  |  |  | 19,187,375 |  |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration